Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Sesques

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Journal of Immunological Methods|October 24, 2025
Preliminary evaluation of a whole blood dual-platform flow cytometry protocol for CAR-T cell quantitation: Toward accreditation and clinical routine applicationRémi Pescarmona, Guillaume Monneret, Eleonore Micoud, et al.
Leukemia & Lymphoma|November 19, 2013
Central nervous system involvement in chronic lymphocytic leukemia: uncommon manifestation with undefined therapeutic managementCédric Rossi, Gabriel Brisou, Lucile Baseggio, et al.
Leukemia & Lymphoma|December 27, 2022
Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomasClara Sortais, Stéphanie Cordeil, Estelle Bourbon, et al.
Leukemia & Lymphoma|September 25, 2015
An 18F-FDG-PET maximum standardized uptake value > 10 represents a novel valid marker for discerning Richter's SyndromeAnne-Sophie Michallet, Pierre Sesques, Kari G Rabe, et al.
Leukemia & Lymphoma|November 15, 2023
Retrospective multicenter comparative study of the efficacy and safety between R-DHAC and R-DHAOx in diffuse large B-cell lymphoma or transformed follicular or marginal zone B lymphoma into aggressive lymphoma, as a second-line treatmentLudovic Fouillet, Elisabeth Daguenet, Emmanuelle Tavernier, et al.
Frontiers in Microbiology|October 18, 2019
Metagenomic Investigation of Torque Teno Mini Virus-SH in Hematological PatientsAntonin Bal, Guy Oriol, Laurence Josset, et al.
Viruses|November 17, 2018
Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient ManagementAntonin Bal, Clémentine Sarkozy, Laurence Josset, et al.
Blood Cancer Journal|November 3, 2025
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trialsValentin Letailleur, Isabelle Chaillol, Fanny Cherblanc, et al.
The American Journal of Surgical Pathology|July 15, 2021
Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of TransdifferentiationAlexis Trecourt, Claire Mauduit, Vanessa Szablewski, et al.
Hematological Oncology|May 4, 2018
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomesLauriane Filliatre-Clement, Delphine Maucort-Boulch, Estelle Bourbon, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Journal of Immunological Methods|October 24, 2025
Preliminary evaluation of a whole blood dual-platform flow cytometry protocol for CAR-T cell quantitation: Toward accreditation and clinical routine applicationRémi Pescarmona, Guillaume Monneret, Eleonore Micoud, et al.
Leukemia & Lymphoma|November 19, 2013
Central nervous system involvement in chronic lymphocytic leukemia: uncommon manifestation with undefined therapeutic managementCédric Rossi, Gabriel Brisou, Lucile Baseggio, et al.
Leukemia & Lymphoma|December 27, 2022
Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomasClara Sortais, Stéphanie Cordeil, Estelle Bourbon, et al.
Leukemia & Lymphoma|September 25, 2015
An 18F-FDG-PET maximum standardized uptake value > 10 represents a novel valid marker for discerning Richter's SyndromeAnne-Sophie Michallet, Pierre Sesques, Kari G Rabe, et al.
Leukemia & Lymphoma|November 15, 2023
Retrospective multicenter comparative study of the efficacy and safety between R-DHAC and R-DHAOx in diffuse large B-cell lymphoma or transformed follicular or marginal zone B lymphoma into aggressive lymphoma, as a second-line treatmentLudovic Fouillet, Elisabeth Daguenet, Emmanuelle Tavernier, et al.
Frontiers in Microbiology|October 18, 2019
Metagenomic Investigation of Torque Teno Mini Virus-SH in Hematological PatientsAntonin Bal, Guy Oriol, Laurence Josset, et al.
Viruses|November 17, 2018
Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient ManagementAntonin Bal, Clémentine Sarkozy, Laurence Josset, et al.
Blood Cancer Journal|November 3, 2025
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trialsValentin Letailleur, Isabelle Chaillol, Fanny Cherblanc, et al.
The American Journal of Surgical Pathology|July 15, 2021
Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of TransdifferentiationAlexis Trecourt, Claire Mauduit, Vanessa Szablewski, et al.
Hematological Oncology|May 4, 2018
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomesLauriane Filliatre-Clement, Delphine Maucort-Boulch, Estelle Bourbon, et al.
Pageof 7